Looking stock over.
Is there 'opposition' from animal/human derived drug companies to PLX plant bio-engineered products?
It seems it has taken extremely long time period to get this form of product into international use?
Can anyone speak to use of drug potentially in joint inflammation?
There appears to be also no plant-derived medical use surface tissue infection. Would I be mistaken therein?
Further, any results data from use in Israel proper patient population?
Has PFE made any sales of PLX licensing worldwide, excepting company home turf and Brazil? Brazil maybe to be gateway for sourcing drug to other nations?
Looking like PLX has uphill fight to get its form of bio-product established.
Any thoughts on hurdle of The Donald hot for USA-based products and production siting?
Still, I am going to buy a small amount and see what transpires.
News 
Market Data 
Discover 
AI
